JPRN-UMIN000048030
Completed
未知
Effects of tofogliflozin treatment on suppression of nocturia and promotion of urinary sodium excretion. - Effects of tofogliflozin treatment on suppression of nocturia and promotion of urinary sodium excretion.
Department of Metabolism and Endocrinology, Akita University Graduate School of Medicine0 sites36 target enrollmentJune 11, 2022
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Department of Metabolism and Endocrinology, Akita University Graduate School of Medicine
- Enrollment
- 36
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Type 2 diabetic patients who have an allergy against SGLT2 inhibitors 2\) Type 2 diabetic patients who are pregnant
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Evaluation of Preventive Effect of tofogliflozin on cardiovascular function in type 2 diabetes with cardiovascular diseasestype 2 diabetes with cardiovascular diseaseJPRN-UMIN000018344tofogliflozin study group30
Unknown
Phase 1
Drug-drug interaction study (2) of TofoglifloziJPRN-jRCT2080221710Chugai Pharmaceutical Co., Ltd.87
Recruiting
Phase 4
Effect of tofogliflozin on pancreatic beta-cell functioType 2 diabetesJPRN-jRCTs011230006akamura Akinobu70
Unknown
Phase 1
Drug-drug interaction study (1) of TofoglifloziType 2 diabetsJPRN-jRCT2080221599Chugai Pharmaceutical Co., Ltd.90
Unknown
Phase 2
Clinical Pharmacology Study of Tofogliflozin --Evaluation of influence by degree of kidney functionType 2 diabetesJPRN-jRCT2080221532Chugai Pharmaceutical Co., Ltd.40